by Indigo | Feb 21, 2023 | 2023, News, Press
BELGIUM – Ghent, 21 February 2023: Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of Continuous Metabolite Monitoring (CMM®) devices utilising proprietary nanophotonics technology, today announces that that an abstract featuring its CMM®...
by Indigo | Jan 4, 2023 | 2023, News, Press
SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trial Several key senior appointments made in Europe and the US, reflecting the growth and evolution from an early stage to a development stage...
by Indigo | Oct 27, 2022 | 2022, News, Press
Indigo establishes a US presence to drive business development and extend talent acquisition Peter brings over 30 years’ experience leading the development & commercialisation of medical devices, including devices for the diabetes market Ghent, 27 October...
by Indigo | Sep 7, 2018 | 2018, Archive, Press, Video
Our CEO Danaë Delbeke explains the process behind our development of a needle-free glucose monitoring device. An interview for Belgian newspaper De Tijd. Language: Dutch. If the video doesn’t play, click here to watch it on...
